Genes for Alcohol Use Disorder and Alzheimer’s Risk Overlap: Study
Genes for Alcohol Use Disorder and Alzheimer’s Risk Overlap: Study
Genetic, transcriptomic, and epigenetic data reveal molecular mechanisms tying these disorders to each other and to immune disfunction.
Genes for Alcohol Use Disorder and Alzheimer’s Risk Overlap: Study
Genes for Alcohol Use Disorder and Alzheimer’s Risk Overlap: Study

Genetic, transcriptomic, and epigenetic data reveal molecular mechanisms tying these disorders to each other and to immune disfunction.

Genetic, transcriptomic, and epigenetic data reveal molecular mechanisms tying these disorders to each other and to immune disfunction.

meta analysis
Ivermectin (Still) Lacks Scientific Support as a COVID-19 Drug
Ivermectin (Still) Lacks Scientific Support as a COVID-19 Drug
Catherine Offord | Aug 2, 2021
A Cochrane review bolsters scientists’ advice that ivermectin should not be used against the disease outside of clinical trials, while a study claiming to have found beneficial effects in patients was withdrawn following allegations of data manipulation.
High Risk of Bias in Early COVID-19 Studies: Meta-Analysis
High Risk of Bias in Early COVID-19 Studies: Meta-Analysis
Max Kozlov | Jan 14, 2021
Few peer-reviewed clinical papers on the pandemic contained original data, and many of those that did had poor experimental design.
Q&A: COVID-19 Infectiousness Peaks Early in Sickness, Study Shows
Q&A: COVID-19 Infectiousness Peaks Early in Sickness, Study Shows
Max Kozlov | Nov 23, 2020
Patients’ viral loads are highest within five days of their first symptoms, emphasizing the need to isolate early to prevent transmission.
Trials Seek to Answer if Vitamin D Could Help in COVID-19
Trials Seek to Answer if Vitamin D Could Help in COVID-19
Abby Olena | Aug 12, 2020
In clinical studies worldwide, researchers are testing the possibility that supplements of the vitamin could prevent or decrease the severity of SARS-CoV-2 infections.
Value of Medical Marijuana for Mental Health Questioned
Value of Medical Marijuana for Mental Health Questioned
Jef Akst | Oct 29, 2019
A meta-analysis of more than 80 studies from the past four decades finds weak evidence to support the use of medicinal cannabis to treat anxiety, depression, and other mental health disorders.
Industry Partners Extensively Involved in Trials They Fund
Industry Partners Extensively Involved in Trials They Fund
Catherine Offord | Oct 5, 2018
A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.
Tamiflu Reviewed Again
Tamiflu Reviewed Again
Kerry Grens | Jan 30, 2015
The controversial antiviral drug earns better marks in the most recent analysis of the evidence. 
EMA Gearing Up for Transparency
EMA Gearing Up for Transparency
Kerry Grens | Jun 16, 2014
The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.  
Updated Review: Tamiflu Is a Bust
Updated Review: Tamiflu Is a Bust
Kerry Grens | Apr 10, 2014
After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.
Resveratrol May Not Extend Life
Hayley Dunning | Jun 20, 2012
A new meta-analysis finds that resveratrol, currently marketed as a life-extending health supplement, may have a negligible effect on lifespan in humans.
FDA Disputes Data Under-Reporting
Sabrina Richards | May 2, 2012
The FDA and NIH dispute reports that clinical trial data is being under-reported.
With All Due Consideration
Mary Beth Aberlin | May 1, 2012
Scientists and their many hats
Tall Women Beware
Edyta Zielinska | Apr 5, 2012
Extra inches may mean a higher chance of getting ovarian cancer.
Bird Flu Prevalence Underestimated
Hannah Waters | Feb 23, 2012
Pooled data from H5N1 bird flu studies suggests that the World Health Organization may be underestimating infection and overestimating fatality.